Your browser doesn't support javascript.
loading
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer.
Riudavets, Mariona; Lamberts, Virginie; Vasseur, Damien; Auclin, Edouard; Aldea, Mihaela; Jovelet, Cécile; Naltet, Charles; Lavaud, Pernelle; Gazzah, Anas; Aboubakar, Frank; Dorta, Miriam; Remon, Jordi; Rouleau, Etienne; Ngocamus, Maud; Nicotra, Claudio; Lacroix, Ludovic; Besse, Benjamin; Mezquita, Laura; Planchard, David.
Afiliación
  • Riudavets M; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Lamberts V; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Vasseur D; Medical Biology and Pathology Department, BMO unit from AMMICa UMS3655/US23, Gustave Roussy, Villejuif, France.
  • Auclin E; Medical and Thoracic Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
  • Aldea M; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Jovelet C; Medical Biology and Pathology Department, BMO unit from AMMICa UMS3655/US23, Gustave Roussy, Villejuif, France.
  • Naltet C; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Lavaud P; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Gazzah A; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Aboubakar F; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Dorta M; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Remon J; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Rouleau E; Medical Biology and Pathology Department, BMO unit from AMMICa UMS3655/US23, Gustave Roussy, Villejuif, France.
  • Ngocamus M; Early Drug Development Department, Institut Gustave Roussy, Villejuif, France.
  • Nicotra C; Early Drug Development Department, Institut Gustave Roussy, Villejuif, France.
  • Lacroix L; Medical Biology and Pathology Department, BMO unit from AMMICa UMS3655/US23, Gustave Roussy, Villejuif, France.
  • Besse B; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Mezquita L; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Laboratory of Translational Genomics and Targeted therapies in solid tumors, Barcelona, Spain. Electronic address: lmezquita@clinic.cat.
  • Planchard D; Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
Clin Lung Cancer ; 23(6): e377-e383, 2022 09.
Article en En | MEDLINE | ID: mdl-35660356
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia